(MENAFN - Gulf Times) A multidisciplinary team of researchers and clinicians at Sidra Medicine, have launched a paediatric cancer biorepository pilot to develop personalised cancer therapies for patients.
Lead by Dr Wouter Hendrickx, Principal Investigator (PI) of the Paediatric Cancer Omics Lab and the Lead PI of the pilot, in close collaboration with Dr William Mifsud, Attending Physician from Sidra Medicine s Anatomic Pathology division, the biorepository is an integrated system that will collect patient samples and match complex data with clinical information.
Dr Wouter Hendrickx said, Personalised medicine is transitioning away from a one size fits all treatment approach towards a more advanced and detailed version, to better manage patients health. This not only helps manage the disease but also offers the best outcomes. The development of the biorepository pilot is a true showcase of how our research, pathology, patient care services have collaborated to offer the possi